Edition:
United Kingdom

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

161.17USD
21 Jun 2018
Change (% chg)

$-1.83 (-1.12%)
Prev Close
$163.00
Open
$163.01
Day's High
$163.07
Day's Low
$160.69
Volume
51,550
Avg. Vol
72,070
52-wk High
$166.47
52-wk Low
$112.48

Chart for

About

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research... (more)

Overall

Beta: 0.72
Market Cap(Mil.): $4,582.91
Shares Outstanding(Mil.): 37.39
Dividend: 0.32
Yield (%): 1.04

Financials

  TECH.OQ Industry Sector
P/E (TTM): 60.42 82.81 32.74
EPS (TTM): 2.03 -- --
ROI: 6.09 2.00 14.38
ROE: 8.32 3.49 16.08

BRIEF-Bio-Techne Q3 GAAP Earnings Per Share $0.52

* Q3 EARNINGS PER SHARE VIEW $1.14 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

02 May 2018

BRIEF-Bio-Techne Q2 GAAP Earnings Per Share $1.29

* QTRLY GAAP EPS SAW A ONE-TIME BENEFIT OF $0.94 FROM TAX REFORM Source text for Eikon: Further company coverage:

06 Feb 2018

BRIEF-Bio-Techne Acquires Atlanta Biologicals Inc

* BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​

02 Jan 2018

Earnings vs. Estimates